Syapse: Funding, Investors & Team (Sep 2026)
To accomplish more exact consideration for each understanding, we want to change genuine proof into experiences that can straightforwardly affect care. At Syapse, that is true consideration. It's found in the manner we engage medical services associations to cooperate in dynamic, straightforward organizations, conveying total patient bits of knowledge to respond to the inquiries that matter and afterward deliberately applying it at where patients get care - driving genuine effect for disease patients and then some.
Syapse has raised $65.0M across 2 funding rounds on record, the most recent an undisclosed round of $35.0M announced in Jul 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Syapse Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Syapse Funding Rounds
Syapse raised $30.0M in an undisclosed round announced in May 2020.
2.2 years later, an undisclosed round of $35.0M was announced in Jul 2022.
Syapse Founders and Leadership Team
Contact details for the Syapse team: 1 of 2 have an email address on file.
Start 14-day free trial →Syapse Funding Compared to Other Biotechnology Startups
Syapse's latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Syapse in Biotechnology and San Francisco
Companies Similar to Syapse
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Syapse Funding FAQs
What does Syapse do?
To accomplish more exact consideration for each understanding, we want to change genuine proof into experiences that can straightforwardly affect care. At Syapse, that is true consideration. It's found in the manner we engage medical services associations to cooperate in dynamic, straightforward organizations, conveying total patient bits of knowledge to respond to the inquiries that matter and afterward deliberately applying it at where patients get care - driving genuine effect for disease patients and then some.
How much funding has Syapse raised?
Syapse has raised $65.0M across 2 rounds on record. The most recent is an undisclosed round of $35.0M announced in Jul 2022.
When did Syapse last raise funding?
Syapse's most recent funding round on record is an undisclosed round of $35.0M, announced in Jul 2022.
Who founded Syapse?
FundedIQ lists Jonathan Hirsch (Founder) at Syapse.
Who is the CEO of Syapse?
Ken Tarkoff is listed as CEO at Syapse.
Where is Syapse headquartered?
Syapse is based in San Francisco, California, United States.
How many employees does Syapse have?
Syapse is in the 101-250 employee band.
How does Syapse's funding compare to other Biotechnology startups?
Syapse's latest round of $35.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Syapse Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Syapse is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.